CANTON, CT >> Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its quarter ended September 30, 2022. “Revenues in Q3 were significantly ahead of last year and we expect continued strong sales performance through the end of the year”, said Ross Bjella, Kelyniam’s Chairman and CEO. “The quarter over quarter...Read More